We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi-Aventis Sales Rise in Fourth Quarter Despite Generic Competition
Sanofi-Aventis Sales Rise in Fourth Quarter Despite Generic Competition
February 7, 2006
Sanofi-aventis, the world’s third-largest pharmaceutical firm, reported sales grew nearly 5 percent in the fourth quarter of 2005, despite U.S. generic competition on its blockbuster allergy drug Allegra and three other products.